The Cooper Companies, Inc. (COO) NASDAQ
59.49
-0.7(-1.16%)
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
59.49
-0.7(-1.16%)
Currency In USD
| Previous Close | 60.19 |
| Open | 59.98 |
| Day High | 60.15 |
| Day Low | 59.15 |
| 52-Week High | 89.83 |
| 52-Week Low | 58.89 |
| Volume | 4.15M |
| Average Volume | 2.34M |
| Market Cap | 11.61B |
| PE | 29.6 |
| EPS | 2.01 |
| Moving Average 50 Days | 65.36 |
| Moving Average 200 Days | 73 |
| Change | -0.7 |
CooperCompanies Announces Release Date for First Quarter 2026
GlobeNewswire Inc.
Feb 05, 2026 9:15 PM GMT
SAN RAMON, Calif., Feb. 05, 2026 (GLOBE NEWSWIRE) -- CooperCompanies (Nasdaq: COO), a leading medical device company, announced today it will report first quarter 2026 financial results on Thursday, March 5, 2026, at 4:15 PM ET. Following the relea
CooperCompanies to Present at the J.P. Morgan Healthcare Conference
GlobeNewswire Inc.
Dec 29, 2025 9:15 PM GMT
SAN RAMON, Calif., Dec. 29, 2025 (GLOBE NEWSWIRE) -- CooperCompanies (Nasdaq: COO), a leading medical device company, announced today it will participate at the J.P. Morgan Healthcare Conference on Wednesday, January 14, 2026. Al White, President a
CooperCompanies Appoints Walter M Rosebrough, Jr. to its Board of Directors
GlobeNewswire Inc.
Dec 23, 2025 1:00 PM GMT
Enters into Cooperation Agreement with Browning WestSAN RAMON, Calif., Dec. 23, 2025 (GLOBE NEWSWIRE) -- CooperCompanies (Nasdaq: COO), a leading medical device company, announced today that the Company’s Board of Directors (the “Board”) has appoin